List view / Grid view

Professor Yoshinori Fujiyoshi

 

news

CeSPIACE: New peptide drug blocks COVID-19 variants

Scientists have developed CeSPIACE, a peptide drug that offers broad…

20 March 2025 | By

Scientists have developed CeSPIACE, a peptide drug that offers broad protection against COVID-19 variants, including Omicron XBB.1.5. Find out how it targets a stable part of the virus’s spike protein, making it resistant to mutations.